Evidence map›Paper›PMID 33649932›Full record

ArticleMolecular biotechnology2021

Alfalfa Plants (Medicago sativa L.) Expressing the 85B (MAP1609c) Antigen of Mycobacterium avium subsp. paratuberculosis Elicit Long-Lasting Immunity in Mice.

Elizabeth Monreal-Escalante, Cristhian Sández-Robledo, Amalia León-Gallo, Virginie Roupie, Kris Huygen, Sawako Hori-Oshima, Mario Arce-Montoya, Sergio Rosales-Mendoza, Carlos Angulo

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Elizabeth Monreal-Escalante *Immunology and Vaccinology Group, Centro de Investigaciones Biológicas del Noroeste, SC, Instituto Politécnico Nacional, 195, Playa Palo de Santa Rita Sur, La Paz, Baja California Sur, 23096, Mexico.
Cristhian Sández-Robledo *Immunology and Vaccinology Group, Centro de Investigaciones Biológicas del Noroeste, SC, Instituto Politécnico Nacional, 195, Playa Palo de Santa Rita Sur, La Paz, Baja California Sur, 23096, Mexico.
Amalia León-GalloFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava Num. 6, Zona Universitaria., San Luis Potosí, San Luis Potosi, 78210, Mexico.
Virginie RoupieVeterinary and Agrochemical Research Institute, VAR-CODA-CERVA, 1180, Brussels, Belgium.
Kris HuygenScientific Service Immunology, Scientific Institute of Public Health WIV-ISP (Site Ukkel), 642 Engelandstraat, 1180, Brussels, Belgium.
Sawako Hori-OshimaInstituto de Investigaciones en Ciencias Veterinarias, Universidad Autónoma de Baja California, Carretera San Felipe Km. 3.5, Fraccionamiento Laguna Campestre, Mexicali, Baja California, 21387, Mexico.
Mario Arce-MontoyaImmunology and Vaccinology Group, Centro de Investigaciones Biológicas del Noroeste, SC, Instituto Politécnico Nacional, 195, Playa Palo de Santa Rita Sur, La Paz, Baja California Sur, 23096, Mexico.
Sergio Rosales-MendozaFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava Num. 6, Zona Universitaria., San Luis Potosí, San Luis Potosi, 78210, Mexico. rosales.s@uaslp.mx.
Carlos AnguloImmunology and Vaccinology Group, Centro de Investigaciones Biológicas del Noroeste, SC, Instituto Politécnico Nacional, 195, Playa Palo de Santa Rita Sur, La Paz, Baja California Sur, 23096, Mexico. eangulo@cibnor.mx.ORCID http://orcid.org/0000-0002-7965-1679
Autonomous University of San Luis Potosí · MXInstituto Politécnico Nacional · MXCentro de Investigaciones Biológicas Margarita Salas · ESInstitut Scientifique de Santé Publique · BEUniversidad Autónoma de Baja California · MXVeterinary and Agrochemical Research Centre · BE

Funding

Consejo Nacional de Ciencia y Tecnología CB-2010-01-151818Consejo Nacional de Ciencia y Tecnología INFR-2014-01-225843Consejo Nacional de Ciencia y Tecnología INFR- 2014-01-225924Universidad Autónoma de San Luis Potosí FAI/UASLP/2015
6 · The paper itself

Abstract

Mycobacterium avium subsp. paratuberculosis (MAP) is the etiological agent of Paratuberculosis, a contagious, untreatable, and chronic granulomatous enteritis that results in diarrhea, emaciation, and death in farmed ruminants (i.e., cattle, sheep, and goats). In this study, the Ag85B antigen from MAP was expressed in transgenic alfalfa as an attractive vaccine candidate. Agrobacterium-mediated transformation allowed the rescue of 56 putative transformed plants and transgenesis was confirmed in 19 lines by detection of the Ag85B gene (MAP1609c) by PCR. Line number 20 showed the highest Ag85B expression [840 ng Ag85B per gram of dry weight leaf tissue, 0.062% Total Soluble Protein (TSP)]. Antigenicity of the plant-made Ag85B was evidenced by its reactivity with a panel of sera from naturally MAP-infected animals, whereas immunogenicity was assessed in mice immunized by either oral or subcutaneous routes. The plant-made Ag85B antigen elicited humoral responses by the oral route when co-administered with cholera toxin as adjuvant; significant levels of anti-85B antibodies were induced in serum (IgG) and feces (IgA). Long-lasting immunity was evidenced at day 180 days post-first oral immunization. The obtained alfalfa lines expressing Ag85B constitute the first model of a plant-based vaccine targeting MAP. The initial immunogenicity assessment conducted in this study opens the path for a detailed characterization of the properties of this vaccine candidate.

Indexed as

ImmunityAdjuvants, ImmunologicAdministration, OralAnimalsAntibodies, BacterialAntigens, BacterialImmunizationMedicago sativaMiceMice, Inbred BALB CMycobacterium avium subsp. paratuberculosisPlants, Genetically ModifiedAdjuvants, ImmunologicAntibodies, BacterialAntigens, Bacterial85B antigenAlfalfaOral vaccineParatuberculosisPlant-made vaccine

Identifiers

PMID33649932
PMCPMC7920848
OpenAlexW3134822613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.